Menu

Syros Pharmaceuticals, Inc. SYRS

Full chart Compare
Set alert

Price alert · SYRS

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 9, 2026, 4:00 PM EST

0.11 +0.11 +26,700.00%

After hours · Nov 9, 4:00 PM ET

0.0005 Day range 0.0005
0.0001 52-week range 0.02
YTD
+14.29%
1 year
-20.00%

Revenue & Expenses

Revenue → Gross Profit: $9.94MGross Profit → Expenses: $9.94MExpenses → Selling, General & Admin: $28.28MExpenses → Research & Development: $108.15MExpenses → Other Operating Expenses: $2.49MExpenses → Interest Expense: $5.13MExpenses → Other Expenses: $30.46MNet Loss → Expenses: $164.57MGross Profit$9.94MNet Loss$164.57MExpenses$174.51MSelling, General & Admin$28.28MResearch & Development$108.15MOther Operating Expenses$2.49MInterest Expense$5.13MOther Expenses$30.46MRevenue$9.94M

Latest period ending Dec 31, 2023 · select a line to chart its full history

SYRS annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
9.94M14.88M23.49M15.09M1.98M
9.94M14.88M23.49M15.09M1.98M
-128.99M-135.87M-99.42M-82.30M-77.74M
-164.57M-94.65M-86.56M-84.04M-75.44M
-5.81-7.49-13.84-18.20-18.80
SYRS annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
141.65M170.55M95.39M177.07M41.73M
168.17M244.49M182.94M213.25M149.98M
151.51M116.75M97.72M122.70M70.79M
62.08M63.57M65.19M66.21M25.92M
16.66M127.74M85.22M90.55M79.18M
SYRS annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-109.71M-123.06M-99.54M-57.36M-60.25M
37.34M67.19M-52.65M46.66M-11.73M
43.46M131.04M70.51M142.95M65.99M
1.29M-1.24M-1.25M-3.34M-12.53M
-28.91M75.17M-81.68M132.25M-6.00M